Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Genome Research
|
May 8, 2024
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 30, 2023
Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines
Paaladinesh Thavendiranathan, Christian Houbois, Thomas H Marwick, et al.
Cancer Research
|
January 11, 2017
Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA
Tong-You Wade Wei, Pei-Yu Wu, Ting-Jung Wu, et al.
Communications Biology
|
February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer
Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 5, 2026
CES1 Deficiency is Associated With Metabolic Reprograming and Endothelial Dysfunction in Pulmonary Arterial Hypertension
Stuti Agarwal, Anuradha Bankar, Lyong Heo, et al.
Journal of Medicinal Chemistry
|
October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer
Eric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Nature Genetics
|
September 7, 2022
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation
Sylvan C Baca, Cassandra Singler, Soumya Zacharia, et al.
Nature Communications
|
November 30, 2022
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential
Jeroen Kneppers, Tesa M Severson, Joseph C Siefert, et al.
The Journal of Biological Chemistry
|
December 3, 2010
Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity
Jianying Dong, Arlene Sereno, William B Snyder, et al.
Genome Biology
|
May 12, 2021
Functional mapping of androgen receptor enhancer activity
Chia-Chi Flora Huang, Shreyas Lingadahalli, Tunc Morova, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Genome Research
|
May 8, 2024
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 30, 2023
Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines
Paaladinesh Thavendiranathan, Christian Houbois, Thomas H Marwick, et al.
Cancer Research
|
January 11, 2017
Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA
Tong-You Wade Wei, Pei-Yu Wu, Ting-Jung Wu, et al.
Communications Biology
|
February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer
Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 5, 2026
CES1 Deficiency is Associated With Metabolic Reprograming and Endothelial Dysfunction in Pulmonary Arterial Hypertension
Stuti Agarwal, Anuradha Bankar, Lyong Heo, et al.
Journal of Medicinal Chemistry
|
October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer
Eric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Nature Genetics
|
September 7, 2022
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation
Sylvan C Baca, Cassandra Singler, Soumya Zacharia, et al.
Nature Communications
|
November 30, 2022
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential
Jeroen Kneppers, Tesa M Severson, Joseph C Siefert, et al.
The Journal of Biological Chemistry
|
December 3, 2010
Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity
Jianying Dong, Arlene Sereno, William B Snyder, et al.
Genome Biology
|
May 12, 2021
Functional mapping of androgen receptor enhancer activity
Chia-Chi Flora Huang, Shreyas Lingadahalli, Tunc Morova, et al.
Page
of 5